Cipla and Mylan have applied for prequalification of dolutegravir
Two major producers of generic drugs, Cipla and Mylan, became the first companies to apply for WHO’s prequalification of dolutegravir (DTG),The Medicines Patent Pool (MPP) announced on November 10, 2016. This is an important step towards improving access to HIV treatment ...